List of Studies ( Metabolite:HexCer 18:1;O2/26:0)
| Study_id | Analysis_id | Study_title | Source | Species | Disease | Institute | Analysis Type |
|---|---|---|---|---|---|---|---|
| ST004168 | AN006919 | Integrative brain omics approach highlights sn-1 lysophosphatidylethanolamine in Alzheimer's dementia | Brain | Human | Alzheimers disease | Emory University | LC-MS |
| ST004049 | AN006694 | Comparison of lipidome from phagosomes containing Pam3csk4-beads vs. uncoupled-beads | Macrophages | Mouse | St Jude Children's Research Hospital | LC-MS | |
| ST004049 | AN006695 | Comparison of lipidome from phagosomes containing Pam3csk4-beads vs. uncoupled-beads | Macrophages | Mouse | St Jude Children's Research Hospital | LC-MS | |
| ST003703 | AN006075 | NAD Depletion in Skeletal Muscle does not Compromise Muscle Function or Accelerate Aging | Muscle | Mouse | Sarcopenia | University of Copenhagen | LC-MS |
| ST003702 | AN006074 | Kupffer cells control neonatal hepatic glucose metabolism via Igf1 signaling - lipidomics analysis of postnatal day 0 murine livers after macropahges depletion using Csf1r conditional KO | Liver | Mouse | University of Bonn | LC-MS | |
| ST003694 | AN006061 | FOLFIRINOX effects on lipidomics in pancreatic cancer cells | Pancreas | Human | Cancer | Pennsylvania State University | LC-MS |
| ST003678 | AN006039 | The effects of cystine limitation stress adaptation (CLSA) on lipidomics changes in pancreatic cancer cells | Pancreas | Human | Cancer | Pennsylvania State University | LC-MS |
| ST003672 | AN006030 | Advanced Lipidomics Using UHPLC-ESI-QTOF-MS/MS Reveals Novel Lipids in Hibernating Syrian Hamsters | Brain | Golden hamster | Universidad CEU San Pablo | LC-MS | |
| ST003645 | AN005984 | Targeting the c-MYC/ELOVL6 Pathway Alters Cell Membrane Mechanics and Enhances Chemotherapeutic Efficacy in Pancreatic Cancer | Cultured cells | Human | Cancer | Universidad Francisco de Vitoria - Hospital 12 de Octubre | LC-MS |
| ST003637 | AN005973 | lomitapide effects on lipidomics | Pancreas | Human | Cancer | Pennsylvania State University | LC-MS |
| ST003629 | AN005962 | Impact of human PSMC5 gene mutations on neuronal development: Lipid profiling of PSMC5 mutant T cells | T-cells | Human | Brain disease | Leibniz Institute for Plasma Science and Technology | LC-MS |
| ST003614 | AN005939 | Kupffer cells control neonatal hepatic glucose metabolism via Igf1 signaling - lipidomics analysis of postnatal day 0 murine livers after macropahges depletion | Liver | Mouse | University of Bonn | LC-MS | |
| ST003578 | AN005876 | NRF2 supports non-small cell lung cancer growth independently of CBP/p300-enhanced glutathione synthesis | Cultured cells | Human | Cancer | Genentech Inc. | FIA-MS |
| ST003527 | AN005794 | Combining antibiotics alters the longitudinal maturation of gut microbiota and its short chain fatty acid metabolites in extremely and very preterm infants | Feces | Human | Gastrointestinal disease | Seoul National University | GC-MS/LC-MS |
| ST003477 | AN005712 | Biocrates Test | Blood | Human | Hannover Medical School | LC-MS | |
| ST003410 | AN005601 | Lipidomics Analysis of ER+ Breast Cancer Cells Treated with Giredestrant and Palbociclib | Cultured cells | Human | Cancer | Genentech Inc. | LC-MS |
| ST003403 | AN005585 | The double-edged role of FASII regulator FabT in Streptococcus pyogenes infection - Metabolomics | Bacterial cells | Streptococcus pyogenes | Bacterial infection | INSERM | LC-MS |
| ST003364 | AN005511 | Deep lipidomic profiling reveals sex dimorphism of lipid metabolism in fibro-calcific aortic valve disease | Aortic valve tissue | Human | Heart disease | Technical University Dresden | LC-MS |
| ST003341 | AN005475 | Untargeted Lipidomic Profiling of Canine Cancer Cell Lines | Cultured cells | Dog | Cancer | Kojin Therapeutics, Inc. | LC-MS |
| ST003326 | AN005448 | Lipidome profiling in non-alcoholic steatohepatitis identifies phosphatidylserine synthase 1 as a regulator of hepatic lipoprotein metabolism | Liver | Mouse | Liver disease | University of Melbourne | LC-MS |
| ST003130 | AN005133 | Pulmonary maternal immune activation does not extend through the placenta but leads to fetal metabolic adaptation - Maternal blood | Blood | Mouse | University of Copenhagen | LC-MS | |
| ST003129 | AN005131 | Pulmonary maternal immune activation does not extend through the placenta but leads to fetal metabolic adaptation - Maternal liver | Liver | Mouse | University of Copenhagen | LC-MS | |
| ST003090 | AN005054 | Analysis of lipid profiles of N2A-Pz1-KO cells expressing tdTOMATO-vector (mock), TMEM120A, or TMEM120B | Cultured cells | Mouse | Rutgers University | LC-MS | |
| ST002873 | AN004709 | The ganglioside GM3 protects against abdominal aortic aneurysm (AAA) by suppressing ferroptosis | Blood | Human | Abdominal aortic aneurysm | Tianjin Medical University | LC-MS |
| ST002843 | AN004653 | Leukemia inhibitory factor suppresses hepatic de novo lipogenesis and induces cachexia (Tamoxifen) | Liver | Mouse | Cancer | Rutgers University | LC-MS |
| ST002842 | AN004651 | Leukemia inhibitory factor suppresses hepatic de novo lipogenesis and induces cachexia (Fenofibrate) | Liver | Mouse | Cancer | Rutgers University | LC-MS |
| ST002787 | AN004534 | Metabolomic analysis of gut metabolites in colorectal cancer patients: correlation with disease development and outcome | Feces | Human | Cancer | Wuhan University of Science and Technology | LC-MS |
| ST002781 | AN004528 | Lipidomics analysis of maternal obesity model - wild type | Liver | Mouse | Fatty liver disease | University of Bonn | MS(Dir. Inf.) |
| ST002781 | AN004528 | Lipidomics analysis of maternal obesity model - wild type | Liver | Mouse | Obesity | University of Bonn | MS(Dir. Inf.) |
| ST002747 | AN004456 | Evolutionary genomics identifies host-directed therapeutics to treat intracellular bacterial infections | Cultured cells | Human | CZ Biohub | LC-MS | |
| ST002747 | AN004456 | Evolutionary genomics identifies host-directed therapeutics to treat intracellular bacterial infections | Cultured cells | Rickettsia parkeri | CZ Biohub | LC-MS | |
| ST002713 | AN004398 | Ranolazine induced metabolic rewiring improves melanoma responses to targeted therapy and immunotherapy - lipidomics | Cultured cells | Human | Cancer | University of Colorado Denver | LC-MS |
| ST002637 | AN004309 | MoTrPAC: Endurance exercise training study in young adult rats, Rat Hippocampus Powder - Untargeted Lipidomics, Reversed-Phase Positive | Hippocampus | Rat | Georgia Institute of Technology | LC-MS | |
| ST002636 | AN004308 | MoTrPAC: Endurance exercise training study in young adult rats, Rat Hippocampus Powder - Untargeted Lipidomics, Reversed-Phase Negative | Hippocampus | Rat | Georgia Institute of Technology | LC-MS | |
| ST002452 | AN004007 | Lipidomic analysis of human brain from frontotemporal dementia cases of with GRN and C9orf72 mutations | Brain | Human | Dementia | University of Sydney | LC-MS |
| ST002400 | AN003908 | Alcohol dehydrogenase 1B is crucial for adipocyte homeostasis | Cultured cells | Human | INSERM | LC-MS | |
| ST002283 | AN003730 | The “ForensOMICS” approach to forensic post-mortem interval estimation: combining metabolomics, lipidomics and proteomics for the analysis human skeletal remains | Bone | Human | University of Central Lancashire | LC-MS | |
| ST002180 | AN003571 | Global, distinctive and personal changes in molecular and microbial profiles induced by specific fibers in humans (Targeted) | Blood | Human | Stanford University | LC-MS | |
| ST002023 | AN003293 | A targeted metabolomics study for assessing rodent thyroid toxicity | Liver | Rat | Thyroid toxicity | Helmholtz Centre for Environmental Research | LC-MS |
| ST002023 | AN003293 | A targeted metabolomics study for assessing rodent thyroid toxicity | Thyroid | Rat | Thyroid toxicity | Helmholtz Centre for Environmental Research | LC-MS |
| ST001888 | AN003059 | A Metabolome Atlas of the Aging Mouse Brain (Study part II) | Brain | Mouse | University of California, Davis | GC-MS/LC-MS | |
| ST001877 | AN003080 | Targeted Sphingolipid analysis of HeLa knockout for expression of GRASP55 | HeLa cells | Human | IBBC, CNR | LC-MS | |
| ST001819 | AN002952 | EC and PVC from 14-15 month-old APOE3/3, APOE3/4 and APOE4/4 mice | Brain | Mouse | Alzheimers disease | Columbia University | LC-MS |
| ST001725 | AN002810 | Lipidomics dataset of Danio rerio optic nerve regeneration model | Eye tissue | Zebrafish | Eye disease | University of Miami | LC-MS |
| ST001673 | AN002731 | Targeted Sphingolipid analysis of HeLa silenced for or overexpressing GOLPH3 or LCS | HeLa cells | Human | École polytechnique fédérale de Lausanne (EPFL) | LC-MS | |
| ST001672 | AN002730 | Targeted Sphingolipid analysis of human Fibroblasts silenced for or overexpressing GOLPH3 | Fibroblast cells | Human | École polytechnique fédérale de Lausanne (EPFL) | LC-MS | |
| ST001637 | AN002677 | A Metabolome Atlas of the Aging Mouse Brain | Brain | Mouse | University of California, Davis | GC-MS/LC-MS | |
| ST001477 | AN002453 | Lipidomics dataset of PTEN deletion-induced nerve regeneration mouse model | Eye tissue | Mouse | Eye disease | University of Miami | LC-MS |
| ST001442 | AN002410 | Human Optic Nerve Glaucoma and Control Lipidomes | Eye tissue | Human | Eye disease | University of Miami | MS(Dir. Inf.) |
| ST001345 | AN002239 | C56BL6 WT or IFNARKO BMDM stimulated with different TLRs (part-V) | Macrophages | Mouse | University of California, Los Angeles | MS(Dir. Inf.) | |
| ST001344 | AN002238 | C56BL6 WT or MyD88KO BMDM stimulated with different TLRs (part-IV) | Macrophages | Mouse | University of California, Los Angeles | MS(Dir. Inf.) | |
| ST001343 | AN002237 | C56BL6 WT or TRIFKO BMDM stimulated with different TLRs (part-III) | Macrophages | Mouse | University of California, Los Angeles | MS(Dir. Inf.) | |
| ST001342 | AN002236 | Timecourse of C56BL6 BMDM stimulated with different TLRs (part-I) | Macrophages | Mouse | University of California, Los Angeles | MS(Dir. Inf.) | |
| ST001341 | AN002235 | C56BL6 BMDM stimulated with different TLRs W/O acetylated LDL (part-II) | Macrophages | Mouse | University of California, Los Angeles | MS(Dir. Inf.) | |
| ST001288 | AN002141 | Subcellular organelle lipidomics in TLR-4-activated macrophages | Macrophages | Mouse | LIPID MAPS | LC-MS | |
| ST001067 | AN001747 | Lipidomics analysis for aged mice femoral muscle (part - IV) | Adipose tissue | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001067 | AN001747 | Lipidomics analysis for aged mice femoral muscle (part - IV) | Brain | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001067 | AN001747 | Lipidomics analysis for aged mice femoral muscle (part - IV) | Liver | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001067 | AN001747 | Lipidomics analysis for aged mice femoral muscle (part - IV) | Muscle | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001066 | AN001745 | Lipidomics analysis for aged mice liver (part-III) | Adipose tissue | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001066 | AN001745 | Lipidomics analysis for aged mice liver (part-III) | Brain | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001066 | AN001745 | Lipidomics analysis for aged mice liver (part-III) | Liver | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001066 | AN001745 | Lipidomics analysis for aged mice liver (part-III) | Muscle | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001065 | AN001743 | Lipidomics analysis for aged mice brain cortex (part-II) | Adipose tissue | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001065 | AN001743 | Lipidomics analysis for aged mice brain cortex (part-II) | Brain | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001065 | AN001743 | Lipidomics analysis for aged mice brain cortex (part-II) | Liver | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001065 | AN001743 | Lipidomics analysis for aged mice brain cortex (part-II) | Muscle | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001063 | AN001740 | Lipidomics analysis for aged mice organs | Adipose tissue | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001063 | AN001740 | Lipidomics analysis for aged mice organs | Brain | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001063 | AN001740 | Lipidomics analysis for aged mice organs | Liver | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001063 | AN001740 | Lipidomics analysis for aged mice organs | Muscle | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST000963 | AN001577 | Lipidomics of inflammation-induced optic nerve regeneration | Eye tissue | Rat | Eye disease | University of Miami | LC-MS |
| ST000917 | AN001501 | Biomarkers of NAFLD progression: a lipidomics approach to an epidemic. Part 3:Urine | Urine | Human | Fatty liver disease | LIPID MAPS | GC-MS/LC-MS |
| ST000916 | AN001495 | Biomarkers of NAFLD progression: a lipidomics approach to an epidemic. Part 2:Plasma | Blood | Human | Fatty liver disease | LIPID MAPS | GC-MS/LC-MS |
| ST000915 | AN001489 | Biomarkers of NAFLD progression: a lipidomics approach to an epidemic. Part 2:Liver | Liver | Human | Fatty liver disease | LIPID MAPS | GC-MS/LC-MS |
| ST000004 | AN000006 | Lipidomics studies on NIDDK / NIST human plasma samples | Blood | Human | LIPID MAPS | LC-MS |
